Christine E Brambs
Overview
Explore the profile of Christine E Brambs including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
169
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hohn A, Wolf B, Forberger M, Brambs C, Gilks B, Hoang L, et al.
Pathobiology
. 2025 Jan;
:1-7.
PMID: 39837304
Introduction: Targeted therapy with antibody-drug conjugates (ADCs) has achieved promising results in the treatment of different solid tumors. Sacituzumab-Govitecan (SG), a humanized anti-Trop2 monoclonal antibody linked with the cytotoxic topoisomerase...
2.
Horn L, Brambs C, Gilks B, Hoang L, Singh N, Hiller G, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766115
Vulvar carcinoma is a rare disease, meeting the criteria for a "rare cancer", but its incidence is increasing, especially in women <60 years of age. Squamous cell carcinoma (VSCC) accounts...
3.
Verta S, Brambs C, Christmann C
Int J Womens Health
. 2025 Jan;
16:2343-2354.
PMID: 39742344
Douglas abscesses (DA) involving the ovaries and/or fallopian tubes and tubo-ovarian abscesses (TOA) constitute a very rare finding in virginal females. Underlying conditions are suspected to play a role in...
4.
Horn L, Brambs C, Aktas B, Dannenmann A, Einenkel J, Hockel M, et al.
Int J Gynecol Pathol
. 2024 Jul;
44(1):2-14.
PMID: 38959413
Knowledge about the morphologic and molecular characteristics of cervical squamous cell carcinomas (CSCCs) associated with uterine prolapse is very limited. Detailed histopathological and immunohistochemical (p16, p53, and cytokeratin 17), as...
5.
Verta S, Brambs C, Christmann C
Int J Womens Health
. 2024 Mar;
16:421-432.
PMID: 38469356
Cystic adenomyomas (CA) are rare. They primarily affect adolescents and young women in their fertile years. Therefore, fertility and pregnancy outcome are of pivotal relevance in this patient collective. Apart...
6.
Hiller G, Hohn A, Mayr D, Brambs C, Horn L
Pathologie (Heidelb)
. 2024 Feb;
45(2):146-147.
PMID: 38334804
No abstract available.
7.
Hiller G, Hohn A, Mayr D, Brambs C, Horn L
Pathologie (Heidelb)
. 2023 Oct;
44(6):392-400.
PMID: 37815668
Background: Histopathological examination is still the backbone for the diagnosis and treatment decision making in endometrial carcinoma (EC). The binary classification of EC into type 1 (mostly endometrioid) and type ...
8.
Brambs C, Horn L, Hiller R, Krucken I, Braun C, Christmann C, et al.
J Cancer Res Clin Oncol
. 2023 Sep;
149(17):15727-15736.
PMID: 37668797
Purpose: Mesonephric-like adenocarcinomas (MLA) of the female genital tract represent a rare and relatively recently described neoplasm exhibiting characteristic morphologic and immunohistochemical findings commonly associated with a KRAS-mutation. Most cases...
9.
Verta S, Alwafai Z, Schleede N, Brambs C, Christmann C, Reichert V, et al.
Am J Case Rep
. 2023 May;
24:e939402.
PMID: 37243328
BACKGROUND Leiomyosarcomas of the vulva (VLMS) are very rare among gynecological malignancies, with a lack of knowledge on clinical presentation, prognosis, and therapeutic management. CASE REPORT The database of the...
10.
Czogalla B, Dotzer K, Sigruner N, von Koch F, Brambs C, Anthuber S, et al.
Biomedicines
. 2022 Nov;
10(11).
PMID: 36359213
Hepatocyte growth factor receptor (HGFR), also known as c-mesenchymal-epithelial transition factor (c-MET), plays a crucial role in the carcinogenesis of epithelial ovarian cancer (EOC). In contrast, the mechanisms contributing to...